Sign in: Staff/Students
Photo: World Obesity Federation
This week The National Institute for Health and Care Excellence (NICE) issued draft guidance recommending the use of a new drug (semaglutide 2.4mg) to help thousands of people living with obesity. The drug, which can be issued via injection, has already helped those using it to reduce their weight by more than 10 per cent.
The recommendation is based on research led by Professor John Wilding, who leads clinical research into obesity, diabetes and endocrinology at the University of Liverpool. Of the announcement he stated:
“It is encouraging to hear that the NICE draft appraisal document should allow use of semaglutide 2.4mg in people with severe obesity attending specialist services such as those that we run in Liverpool and other parts of North West England.
“It is important to remember that this is not a quick fix, and that it will likely only be available for those people with significant complications of their obesity, who are attending specialist services that can also provide appropriate support with diet and physical activity.”
All recent news
Blog: Beat the bank with books on a budget
Staying safe online
Clean energy research initiative celebrates official launch in Kenya
This is Liverpool calling! Opportunity for artists, musicians and creatives to contribute to the city’s Eurovision programme
Blog: Nirwana, a sneak peek into Indonesia’s cultural paradise
"There are multiple #housing crises within the system and it has got a lot worse over time” says Dr @Tom_Moore85 (@livuniplanning) on @BBCPanorama Cost of Living: Can’t Afford My Home
"A complex public health intervention that worked." Study author @profbuchan comments on new analysis of Liverpool mass #COVID19 testing pilot ⬇️ Read more here: https://news.liverpool.ac.uk/2022/11/23/latest-analysis-of-liverpools-covid-testing-pilot-shows-benefits-to-city-population/ @LivUniIPH @bmj_latest
Today @KieranMaguire from @UoLManSchool has been discussing the Glazer family's decision to sell #ManchesterUnited. Read more 👇